Results 11 to 20 of about 402 (126)

Soluble ST2 and Galectin-3 and Progression of CKD [PDF]

Kidney International Reports, 2019
Introduction: Cardiac biomarkers soluble ST2 (sST2) and galectin-3 may reflect cardiac inflammation and fibrosis. It is plausible that these mechanisms may also contribute to the progression of kidney disease.
Mariam L. Alam, Ronit Katz, Keith A. Bellovich, Zeenat Y. Bhat, Frank C. Brosius, Ian H. de Boer, Crystal A. Gadegbeku, Debbie S. Gipson, Jennifer J. Hawkins, Jonathan Himmelfarb, Bryan R. Kestenbaum, Matthias Kretzler, Cassianne Robinson-Cohen, Susan P. Steigerwalt, Courtney Tuegel, Nisha Bansal   +15 more
doaj   +3 more sources

A role for soluble ST2 in vascular remodeling associated with obesity in rats. [PDF]

PLoS ONE, 2013
BackgroundThe function of the Interleukin-33 (IL-33)/ST2 system has been mainly investigated on immunological aspects, but recent data suggest that this pathway plays also an important role in cardiovascular system and adipose tissue.
Ernesto Martínez-Martínez, María Miana, Raquel Jurado-López, Elodie Rousseau, Patrick Rossignol, Faiez Zannad, Victoria Cachofeiro, Natalia López-Andrés   +7 more
doaj   +5 more sources

Diagnostic efficacy of soluble ST2 in pediatric fulminant myocarditis

Frontiers in Pediatrics
Background and aimsEarly identification of fulminant myocarditis (FM) is the key to reducing mortality, but there is still a lack of effective biomarkers for diagnosis.
YanZhu Huang, YiHu Lin, MingHong Fu, WeiFeng Zhang   +3 more
doaj   +3 more sources

Pulmonary Production of Soluble ST2 in Heart Failure [PDF]

Circulation: Heart Failure, 2018
Background: Serum concentrations of ST2 (interleukin-1 receptor-like 1) represent a meaningful prognostic marker in cardiac diseases. Production of soluble ST2 (sST2) may be partially extracardiac. Identification of sST2 sources is relevant to design strategies for modulating its signaling.
Pascual Figal, Domingo Andrés, Pérez Martínez, María T, Asensio López, María del Carmen, Sánchez Mas, Jesús, García García, María E, Martínez, Carlos M, Lencina, Miriam, Jara, Ruben, Januzzi, James L, Lax Pérez, Antonio Manuel   +9 more
openaire   +2 more sources

Clinical value of soluble ST2 in cardiology

Advances in Clinical and Experimental Medicine, 2020
We are constantly looking for new parameters and markers that can help in the assessment of patients with various diseases, including cardiac disorders; this can translate into better care and improved prognosis. Suppression of tumorigenicity 2 (ST2) has recently gained interest as a potential biomarker in many fields: it is involved in many ...
Magdalena Dudek, Marta Kałużna-Oleksy, Jacek Migaj, Ewa Straburzyńska-Migaj   +3 more
openaire   +2 more sources

Soluble ST2 predicts elevated SBP in the community [PDF]

Journal of Hypertension, 2013
Soluble ST2 (sST2) is an emerging prognostic biomarker in patients with existing cardiovascular disease. ST2 and its ligand, interleukin-33 (IL-33), are expressed in endothelial cells, and may play an important role in the development of early atherosclerosis and vascular biology.
Jennifer E, Ho, Martin G, Larson, Anahita, Ghorbani, Susan, Cheng, Ramachandran S, Vasan, Thomas J, Wang, James L, Januzzi   +6 more
openaire   +2 more sources

Association of soluble ST2 with all-cause and cardiovascular mortality in renal transplant recipients: a single-centre cohort study

BMC Nephrology, 2020
Background Soluble ST2 is a novel biomarker of myocardial fibrosis with an established role in prognostication of patients with heart failure. Its role in cardiovascular risk prediction for renal transplant recipients has not been investigated despite ...
Paul A. Devine, Christopher Cardwell, Alexander P. Maxwell   +2 more
doaj   +1 more source

Differences in maternal soluble ST2 levels in the third trimester of normal pregnancy versus preeclampsia

European Journal of Obstetrics & Gynecology and Reproductive Biology: X, 2022
Background: Preeclampsia is associated with intense inflammatory response in pregnancy, and soluble ST2 (sST2) is pathologically increased in this condition. No data exist regarding maternal sST2 levels in normal pregnancy versus preeclampsia in areas of
Prameswari Hawani Sasmaya, Achmad Fitrah Khalid, Dewi Anggraeni, Setyorini Irianti, Mohammad Rizki Akbar   +4 more
doaj   +1 more source

CORELATION OF GLOBAL LONGITUDINAL STRAIN (GLS) – LEFT VENTRICLE AND SOLUBLE SUPRESSION OF TUMORGENICITY 2 (sST2) IN ACUTE HEART FAILURE WITH SYSTOLIC DYSFUNCTION

Majalah Kardiologi Indonesia, 2019
Background  :  Assessment of  left  ventricular  function  in  patients with   acute heart failure is important for prognostication, determination of treatment plan, for decisions related to  expensive device therapies and for assessing response  to ...
Herlina Yulidia, Muhammad Aminuddin, Budi S Pikir   +2 more
doaj   +1 more source

Clinical roles of soluble ST2 for the outcomes of cardiac valve operations [PDF]

Research Ideas and Outcomes, 2016
Soluble ST2 is a novel cardiac biomarker that reflects cardiac injury and the response to treatment. Previous studies showed that ST2 has less confounding and more specific than NT-proBNP. ACCF/AHA has proposed 2013 Guidelines for the Management of Heart
Robert Chen
doaj   +2 more sources